Joanna Horobin, a director at Liquidia Corp ($LQDA), made one open market sale of shares in the last year, totaling $135,850. Her most recent sale occurred on August 19, 2025. This activity ranks 9,137th among 11,678 insiders, far below the average sale amount of $8.6 million across 6.4 transactions. She reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 19, 2025 | Liquidia Corp | $LQDA | Horobin Joanna | Director | S | Common Stock | 5000 | $27.17 | 33,755.0000 | 85,588,108 | 12.90% | 0.01% |
| June 17, 2025 | Liquidia Corp | $LQDA | Horobin Joanna | Director | A | Common Stock | 18396 | $0.00 | 38,755.0000 | 85,172,696 | 90.36% | 0.02% |
| June 20, 2024 | Liquidia Corp | $LQDA | Horobin Joanna | Director | A | Common Stock | 20359 | $0.00 | 20,359.0000 | 75,393,907 | 9999.99% | 0.03% |
| June 7, 2024 | Kymera Therapeutics, Inc. | $KYMR | Horobin Joanna | Not found | M | Common Stock | 8500 | $2.08 | 8,500.0000 | 58,365,499 | 9999.99% | 0.01% |
| June 7, 2024 | Kymera Therapeutics, Inc. | $KYMR | Horobin Joanna | Not found | S | Common Stock | 2187 | $32.65 | 6,313.0000 | 58,365,499 | 25.73% | 0.00% |
| June 7, 2024 | Kymera Therapeutics, Inc. | $KYMR | Horobin Joanna | Not found | S | Common Stock | 6313 | $33.11 | 0.0000 | 58,365,499 | 100.00% | 0.01% |
| June 7, 2024 | Kymera Therapeutics, Inc. | $KYMR | Horobin Joanna | Not found | M | Stock Option (Right to Buy) | 8500 | $0.00 | 33,195.0000 | 58,365,499 | 20.39% | 0.01% |
| June 19, 2023 | Liquidia Corp | $LQDA | Horobin Joanna | Director | A | Non-Qualified Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 64,656,424 | 9999.99% | 0.03% |
| June 15, 2023 | Kymera Therapeutics, Inc. | $KYMR | Horobin Joanna | Director | A | Stock Option (Right to Buy) | 12000 | $0.00 | 12,000.0000 | 53,933,229 | 9999.99% | 0.02% |